The development of peripheral microvasculopathy with chronic metabolic disease in obese Zucker rats: a retrograde emergence?

Daniel Goldman,Brayden D. Halvorson,Nithin J. Menon,Stephanie J. Frisbee,Adam G. Goodwill,Joshua T. Butcher,Phoebe A. Stapleton,Steven D. Brooks,Alexandre C. d'audiffret,Robert W. Wiseman,Julian H. Lombard,Robert W. Brock,I. Mark Olfert,Paul D. Chantler,Jefferson C. Frisbee
DOI: https://doi.org/10.1152/ajpheart.00264.2022
2022-07-31
Abstract:The study of peripheral vasculopathy with chronic metabolic disease is challenged by divergent contributions from spatial (the level of resolution or specific tissue being studied) and temporal origins (evolution of the developing impairments in time). Over many years of studying the development of skeletal muscle vasculopathy and its functional implications, we may be at the point of presenting an integrated conceptual model that addresses these challenges within the obese Zucker rat (OZR) model. At the early stages of metabolic disease, where systemic markers of elevated cardiovascular disease risk are present, the only evidence of vascular dysfunction is at post-capillary and collecting venules, where leukocyte adhesion/rolling is elevated with impaired venular endothelial function. As metabolic disease severity and duration increases, reduced microvessel density becomes evident as well as increased variability in microvascular hematocrit. Subsequently, hemodynamic impairments to distal arteriolar networks emerge, manifesting as increasing perfusion heterogeneity and impaired arteriolar reactivity. This retrograde "wave of dysfunction" continues, creating a condition wherein deficiencies to the distal arteriolar, capillary, and venular microcirculation stabilize and impairments to proximal arteriolar reactivity, wall mechanics and perfusion distribution evolve. This proximal arteriolar dysfunction parallels increasing failure in fatigue resistance, hyperemic responses and O 2 uptake within self-perfused skeletal muscle. Taken together, these results present a conceptual model for the retrograde development of peripheral vasculopathy with chronic metabolic disease and provide insight into the timing and targeting of interventional strategies to improve health outcomes.
What problem does this paper attempt to address?